Image

Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis

Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The overall purpose of this pilot study is to examine the feasibility, acceptability, and tolerability of light and moderate intensity exercise in adults with MGeffect of light vs. moderate intensity exercise on health outcomes. Participants will be enrolled into the NeuroWell exercise program, which is geared toward individuals with neurological disorders or injuries and led by Certified Exercise Physiologists (CEPs) at the HealthPartners Neuroscience Center. A total of 20 people with MG will be enrolled in this study and participate in a small group exercise program 3 times a week for 12 weeks. Participants will be randomized into two exercise groups: 1) Light intensity or 2) Moderate intensity. We hypothesize that light and moderate intensity exercise will be feasible, acceptable, and tolerable in adults with MG and that individuals in the light intensity exercise group will be able to achieve the same improvement in health outcomes as the moderate intensity group.

Eligibility

Inclusion Criteria:

  • Ability to provide and provision of signed and dated informed consent form.
  • Age 18-80
  • Diagnosis of generalized MG.
  • On a stable MG prescription medication regimen for the last 3 months.

Exclusion Criteria:

  • Non-English speaking
  • Regular exercise participation within the month prior to study enrollment or any outside exercise participation during the study intervention period.
  • Significant cognitive impairment of any etiology that would impact study participation.
  • History of heart failure, chronic lung disease, angina or any other condition that causes unreasonable shortness of breath on exertion.
  • History of any serious neurological, psychiatric, or substance use disorders that would impact study participation.
  • Women who are currently pregnant or planning to become pregnant during the study.
  • Any other medical conditions that could affect their ability to participate in exercise for the study duration (as determined by study investigators).
  • Active participation or past participation ≤3 months in any other interventional research study.
  • Unwilling to participate in all study related activities.

Study details
    Myasthenia Gravis

NCT06491238

HealthPartners Institute

22 July 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.